Leon Murphy

Formation of biotechnology companies, scientific strategy and value creation

Global responsibility for 45 FTEs and a diverse portfolio of drug discovery projects spanning oncology, metabolic disorders, regenerative medicine, CNS and the gut microbiome. Extensive experience and success with traditional target-based HTS and chemical biology target-lead discovery. Direct experience leading projects through the candidate selection point and early clinical development. Sustained contributions to Development programs in the Oncology and Neurology portfolios that altered patient stratification decisions and registration strategy. High impact publication record and invited speaker at international conferences. Established key external collaborations with Harvard University and Massachusetts Institute of Technology that led to initiation of drug discovery programs and publications in top tier journals.